Engineered Nanomechanical Oncology
120 nm
core diameter
10 Years
bench validation
Sub-Micron
spatial control
Our foundational platform emerged from nearly a decade of bench investigation at the intersection of electromagnetic field theory and solid-tumour oncology. Early investigations demonstrated that therapeutic toxicity stems primarily from passive biodistribution constraints rather than drug chemistry.
By synthesizing magnetoelectric cores capable of responding to external magnetic vectors, our team established repeatable drug-carrying mechanisms that penetrate dense tumour microenvironments without relying on systemic circulatory accumulation.
Biophysical Benchmarks
10 Yrs
bench R&D validation
4
registered patent filings
12,000+
laboratory fabrication runs
AIIMS
clinical translation partner
Controlled Cleanroom Infrastructure
Our specialized manufacturing laboratory in India’s biotechnology corridor maintains ISO-certified cleanroom environments for repeatable nanorobot synthesis. In-house microfluidic test benches replicate physiological sheer stress, ensuring batch-to-batch uniformity across core hydrodynamic parameters and surface functionalization.
High-resolution characterization suites, including field-emission scanning electron microscopy and vibrating sample magnetometry, govern our quality release assays. Every production run undergoes automated magnetic dipole verification before cell-culture testing.
We welcome technical discussions with translational oncology investigators, clinical trial sponsors, and biopharma research leaders.